Tag
Elon Musk announced that Neuralink's Blindsight neural implant, designed to restore vision to people who are completely blind by interfacing with the visual cortex, is now awaiting regulatory approval.
Australian researchers kept a human liver alive outside the body for a record seven weeks using an automated normothermic perfusion system, potentially enabling far more transplants and new biomedical research.
A tweet praises Elon Musk and Neuralink for enabling an ALS patient named Jake to control his wheelchair joystick with his mind after ALS took away his ability to use it.
Science Corporation的Prima系统结合视网膜植入物与摄像头眼镜,帮助晚期黄斑变性患者恢复视力,超80%使用者可阅读和使用手机,已在欧洲获批并等待美国FDA批准。
Science Corporation CEO Max Hodak announced at TechCrunch Disrupt that the company has implanted its vision-restoring PRIMA chip into its first Stargardt disease patient, with the patient already able to read letters during rehabilitation. The company plans larger field-of-view next-generation implants within a year, aiming to approach native visual acuity over five years.
An MIT class project from 2017 evolved into Encora Therapeutics, whose wristband device using mechanical vibration to reduce tremors has now received FDA clearance for treating essential tremor, following years of development and clinical trials.
Austrian company Med-El launched the TICI Unico, the world's first commercially available fully implantable cochlear implant, which removes external processors and enables round-the-clock hearing. It has received European regulatory approval, with the first commercial implantations already performed.
A blind patient with Stargardt disease regained the ability to read a letter after receiving the PRIMA implant in a clinical trial, showing promise for treating this form of blindness.
A new wearable headset by Flow Neuroscience is now available in the US for treating depression, offering low-intensity electrical stimulation to the brain as an alternative to medication.
MIT Lincoln Laboratory's AI-GUIDE, a portable AI-powered medical device for vascular access, has won the 2026 Excellence in Technology Transfer Award and is being commercialized to improve survival rates in trauma care.
Abbott has received FDA authorization for the Libre Duo, the first continuous glucose monitor that measures both glucose and ketone levels to help prevent diabetic ketoacidosis. The device is designed to provide early warnings for ketone buildup in diabetic patients.
This commemorates the 40th anniversary of catheter ablation, highlighting Dr. Melvin Scheinman's contributions to this medical procedure.
A blood drawing machine has been introduced in China, designed to automate the process of collecting blood samples for medical purposes.
MIT engineers have developed a tiny ingestible capsule that can continuously measure core body temperature with high accuracy, enabling improved health monitoring in various applications such as infection detection and fever tracking.
The FDA has authorized the first wearable device that continuously monitors both ketone and blood sugar levels, helping people with diabetes detect dangerous complications early.
The tweet highlights a Chinese-made patient transfer bed with one-touch remote control that reduces physical strain for patients.
A Japanese company called Iris has developed Nodoca, an AI-powered device that analyzes throat images to diagnose influenza in seconds, eliminating uncomfortable nasal swabs. Already approved in Japan and used at over 2,000 institutions, it is expanding to detect other conditions like Covid-19 and potentially lifestyle diseases.
The Verge reviews CipherX's Microdot patches, a new pain-free permanent tattooing technology that uses microscopic biodegradable needles to deposit pigment, potentially making tattoos available by mail.
Johnson & Johnson received marketing authorization for its robotic surgery device, entering the US market.
A device called the Eye-in-a-Care-Box (ECaBox) can revive eyes from dead donors by perfusing them with oxygen-rich fluid, preserving retinal function and potentially enabling whole-eye transplants.